Featured Press Releases

Serge Messerlian Appointed CEO of Creyon Bio, Leveraging Decades of Experience in Company Building and Strategic Collaborations

Serge Messerlian Appointed CEO of Creyon Bio, Leveraging Decades of Experience in Company Building and Strategic Collaborations

Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

  • 13 Apr 2025

A landmark clinical trial co-led by Hospital for Special Surgery (HSS) has found that blocking...

Avenacy Unveils the Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market

Avenacy Unveils the Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market

HOOKIPA Pharma announces the completion of enrollment in its Phase 1b clinical trial evaluating HB-500 for the treatment of HIV

HOOKIPA Pharma announces the completion of enrollment in its Phase 1b clinical trial evaluating HB-500 for the treatment of HIV

Mayo Clinic researchers have developed a first-in-kind, fully humanized 3D bioprinted human skin model using CollPlant

Mayo Clinic researchers have developed a first-in-kind, fully humanized 3D bioprinted human skin model using CollPlant's rhCollagen-based BioInk

Thermo Fisher Scientific Unveils Integrated Platform to Enhance Biologics Development

Thermo Fisher Scientific Unveils Integrated Platform to Enhance Biologics Development

Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection in two single-dose vial strengths

Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection in two single-dose vial strengths

  • Glenmark Pharmaceuticals
  • 30 Jul 2026
EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

  • BD (Becton, Dickinson and Company)
  • 29 Jul 2026
Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform

Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform

  • Excedr
  • 28 Jul 2026
InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of the Worldwide Launch of Its Non-Injectable Peptide Platform

InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of the Worldwide Launch of Its Non-Injectable Peptide Platform

  • InstaMed® Pharmaceuticals
  • 28 Jul 2026
FDA Clears Roche

FDA Clears Roche's cobas® BV/CV Assay, Enabling Fast and Highly Accurate Diagnosis of Vaginitis

  • Roche
  • 27 Jul 2026
China Approves Haisco

China Approves Haisco's Class 1 Innovative Drug, Ciprocopan Succinate Tablets, Providing a New Treatment Option for Patients with PNH

  • Haisco Pharmaceutical Group Co., Ltd.
  • 24 Jul 2026
The Digital Pharma Advances Conference 2026

Most Popular
July   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.